echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Luye Pharma grants the exclusive rights to the Japanese market of Towa Pharmaceuticals' Mindahi Transdermal Patch

    Luye Pharma grants the exclusive rights to the Japanese market of Towa Pharmaceuticals' Mindahi Transdermal Patch

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 18, Luye Pharmaceuticals announced that its subsidiary Luye Pharmaceuticals (Switzerland) and Towa Pharmaceutical have reached an agreement to grant the latter the exclusive right to develop and commercialize Lisz’s Mingta day transdermal patch in the Japanese market.


    Liss' Mindo Day transdermal patch is used to treat Alzheimer's disease and is an innovative preparation independently developed by Luye Pharma.


    At present, the application for marketing of Liss' Mingdori transdermal patch in Europe has been accepted by the European Union authorities, and it has entered the clinical stage in China, and will soon enter the phase III clinical trial in Japan.


    According to the agreement, Donghe Pharmaceuticals will obtain the exclusive right to develop and commercialize Liss’ Mindori transdermal patches in the Japanese market.


    Alzheimer's disease has become a major health problem worldwide.


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.